Streetbeat News

Products Services

VERB

Verb Technology announced new technology integrations for its MARKET.live platform, leading to a rise in its share prices.

Portfolio Pulse from Luke J Jacobi

November 06, 2023 | 1:38 pm

AMPX

Amprius Technologies, Inc. (NYSE:AMPX) has secured purchase orders from three electric aviation manufacturers for custom cells from its 450 Wh/kg ultra-high-energy density platform. The cells, developed in collaboration with Amprius' strategic customers, are designed to meet unique high-altitude pseudo satellite (HAPS) qualification requirements and operate in challenging environments. The new cells offer greater energy density and longer cycle life than the previous 400 Wh/kg platform. Commercialization of these new cells is scheduled before the end of the year.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:36 pm

KA

Kineta, Inc. (NASDAQ:KA) has presented positive data from its ongoing VISTA-101 Phase 1/2 clinical trial evaluating KVA12123, its VISTA blocking immunotherapy, in patients with advanced solid tumors. The data shows excellent safety and tolerability, with no evidence of CRS-associated Cytokines. The pharmacokinetic data and biomarker assessments demonstrate the drug's potential efficacy and confirm its mechanism of action. Additional monotherapy and combination therapy clinical data are anticipated in Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:34 pm

IGXT

TLRY

IntelGenx Corp. and Tilray Brands Inc. have entered into a second amendment to their November 2018 license, development and supply agreement for the co-development and commercialization of cannabinoid-infused VersaFilm products. The amendment settles IntelGenx's arbitration claim against Tilray and includes an initial purchase order from Tilray for three SKUs. The agreement also allows for IntelGenx's co-development and commercialization of CBD, THC, and combination THC:CBD products with additional partners, and removes any royalties paid to or from Tilray.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:34 pm

MYO

Myomo, Inc. (NYSE:MYO), a wearable medical robotics company, announced that the Centers for Medicare & Medicaid Services (CMS) has posted a proposed Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule payment rate for the MyoPro. The proposed rates for the two HCPCS codes describing the MyoPro are $31,745.42 and $62,457.28. The final rule classifying the MyoPro as a brace will enable reimbursement on a lump sum basis from January 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:32 pm

BAX

Baxter International Inc. (BAX) has announced new data indicating that its Sharesource remote patient management (RPM) digital platform, when used with an automated peritoneal dialysis (PD) system, is associated with a 77% reduction in risk of PD technique failure. The data also shows that HDx therapy enabled by Theranova dialyzer can help reduce annual water consumption by 27% and annual electricity usage by 17%, and associated costs, in comparison with online HDF (hemodiafiltration).

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:32 pm

CADL

Candel Therapeutics has presented preclinical data from its enLIGHTEN discovery platform at the Society for Immunotherapy of Cancer (SITC). The first experimental agent presented is Alpha-201-Macro1, an investigational viral immunotherapy designed to activate innate immune surveillance.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:31 pm

CLDX

Celldex Therapeutics has announced positive data from its phase 2 trial treating urticaria refractory, leading to a rise in its share prices.

Portfolio Pulse from Luke J Jacobi

November 06, 2023 | 1:25 pm

AAPL

Apple Inc. is reportedly developing an in-house battery for its future mobile products, which could result in iPhones with significantly improved battery life. The new batteries are expected to be used in products released after 2025. There are also rumors that Apple is preparing to manufacture batteries for its self-driving car, potentially in collaboration with Taiwanese battery makers.

Portfolio Pulse from Benzinga Neuro

November 06, 2023 | 1:24 pm

TBLA

Taboola (NASDAQ:TBLA) has announced advancements in its Generative AI technology for advertisers. The new feature, Taboola Generative AI AdMaker, allows advertisers to adjust existing creative assets, speeding up campaign launches. The technology has been adopted by over 3,500 clients globally and is used in 25% of all new creative assets created by Taboola's self-service advertisers. The technology has shown to outperform campaigns that did not use it.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 1:23 pm